BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/06/2010

FDA Releases Guidance for Industry on Developing Medical Products for Systemic Lupus Erythematosus Treatment

The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for pharmaceutical companies to develop treatments for systemic lupus erythematosus (SLE), a chronic autoimmune disease, and has finalized two related guidance documents on lupus nephritis treatment.

Source: Federal Register — Health and Human ServicesOpen original release →